|
|
||||||||
Transgene1


*
Committee on Immunology and
Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637
We have characterized a novel substrate for somatic hypermutation,
confirming that non-Ig sequences can be targeted for mutation and
demonstrating that this substrate allows for the rapid assay for
mutations. An artificial sequence containing alternating
EcoRV and PvuII sites (EPS) was inserted into
the V
167 transgene, which is known to be a target for mutation. To
assay for somatic hypermutation, the EPS is amplified using flanking
transgene primers, and the PCR product is subsequently digested with
either EcoRV or PvuII. A mutation is seen as
the appearance of a larger fragment, indicating a base change in a
restriction enzyme site. The original transgene, V
167/EPS, showed
evidence of a low level of mutation in both splenic hybridomas and
Peyers patch-derived or immunized splenic B220+ cells
with high peanut agglutinin levels. Two derivative lines of V
167/EPS
were made, V
167/POX and V
167/PEPS. While none of the V
167/POX
transgenic lines demonstrated mutation, the V
167/PEPS transgene was
highly mutated in B220+ splenic B cells with high peanut
agglutinin levels at a frequency similar to that of endogenous Ig
genes. An analysis of splenic RNA from the unimmunized transgenic mice
indicated that the levels of stable message in splenic B cells could
not be correlated with the mutation seen in GC B cells. The mutable
V
167/PEPS transgenic line is a unique tool to study somatic
hypermutation in vivo.
This article has been cited by other articles:
![]() |
S. Unniraman and D. G. Schatz Strand-Biased Spreading of Mutations During Somatic Hypermutation Science, August 31, 2007; 317(5842): 1227 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kim, G. Bozek, J. C. Lo, and U. Storb Different Mismatch Repair Deficiencies All Have the Same Effects on Somatic Hypermutation: Intact Primary Mechanism Accompanied by Secondary Modifications J. Exp. Med., July 5, 1999; 190(1): 21 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Shapiro, K. Aviszus, D. Ikle, and L. J. Wysocki Predicting Regional Mutability in Antibody V Genes Based Solely on Di- and Trinucleotide Sequence Composition J. Immunol., July 1, 1999; 163(1): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. STORB, A. PETERS, N. KIM, H.M. SHEN, G. BOZEK, N. MICHAEL, J. HACKETT, E. KLOTZ, J.D. REYNOLDS, L.A. LOEB, et al. Molecular Aspects of Somatic Hypermutation of Immunoglobulin Genes Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 227 - 234. [Abstract] [PDF] |
||||
![]() |
U. Storb, E. L. Klotz, J. Hackett Jr., K. Kage, G. Bozek, and T. E. Martin A Hypermutable Insert in an Immunoglobulin Transgene Contains Hotspots of Somatic Mutation and Sequences Predicting Highly Stable Structures in the RNA Transcript J. Exp. Med., August 17, 1998; 188(4): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |